{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:18:08Z","timestamp":1770974288796,"version":"3.50.1"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7923","type":"journal-article","created":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T18:11:28Z","timestamp":1493575888000},"page":"1071-1077","source":"Crossref","is-referenced-by-count":3,"title":["Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient"],"prefix":"10.2169","volume":"56","author":[{"given":"Reiko","family":"D Hayashi","sequence":"first","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Nishizawa","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujishima","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takekazu","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyunji","family":"Kozawa","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunbun","family":"Kita","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Atherosclerosis, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taka-aki","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Otsuki","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Imagawa","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiyoshi","family":"Ichida","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuo","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Institute of Rheumatology, Tokyo Women's Medical University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Atherosclerosis, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Funahashi","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Atherosclerosis, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Matsuzawa Y. Adiponectin: a key player in obesity related disorders. Curr Pharm Des 16: 1896-1901, 2010.","DOI":"10.2174\/138161210791208893"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gutman AB. The past four decades of progress in the knowledge of gout, with an assessment of the present status. Arthritis Rheum 16: 431-445, 1973.","DOI":"10.1002\/art.1780160402"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nakayama DA, Barthelemy C, Carrera G, Lightfoot RW Jr, Wortmann RL. Tophaceous gout: a clinical and radiographic assessment. Arthritis Rheum 27: 468-471, 1984.","DOI":"10.1002\/art.1780270417"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Simkin PA. New standards for uric acid excretion and evidence for an inducible transporter. Arthritis Rheum 49: 735-736, 2003.","DOI":"10.1002\/art.11376"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gibson T. Hyperuricemia, gout and the kidney. Curr Opin Rheumatol 24: 127-131, 2012.","DOI":"10.1097\/BOR.0b013e32834f049f"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jutabha P, Anzai N, Kitamura K, et al. Human sodium phosphate transporter 4 (hNPT4\/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem 285: 35123-35132, 2010.","DOI":"10.1074\/jbc.M110.121301"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. El-Sheikh AA, van den Heuvel JJ, Koenderink JB, Russel FG. Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4. Br J Pharmacol 155: 1066-1075, 2008.","DOI":"10.1038\/bjp.2008.343"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Torres RJ, de Miguel E, Bail\u00e9n R, Banegas JR, Puig JG. Tubular urate transporter gene polymorphisms differentiate patients with gout who have normal and decreased urinary uric acid excretion. J Rheumatol 41: 1863-1870, 2014.","DOI":"10.3899\/jrheum.140126"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Matsuo H, Takada T, Ichida K, et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 1: 5ra11, 2009.","DOI":"10.1126\/scitranslmed.3000237"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Matsuo H, Ichida K, Takada T, et al. Common dysfunctional variants in ABCG2 are a major cause of early-onset gout. Sci Rep 3: 2014, 2013.","DOI":"10.1038\/srep02014"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakayama A, Matsuo H, Shimizu T, et al. Common missense variant of monocarboxylate transporter 9 (MCT9\/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility. Hum Cell 26: 133-136, 2013.","DOI":"10.1007\/s13577-013-0073-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ichida K, Matsuo H, Takada T, et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun 3: 764, 2012.","DOI":"10.1038\/ncomms1756"},{"key":"13","unstructured":"13. Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S. Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes 10: 255-264, 1986."},{"key":"14","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1001\/jama.1991.03470210076036","volume":"266","author":"F Facchini","year":"1991","unstructured":"14. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266: 3008-3011, 1991.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tamba S, Nishizawa H, Funahashi T, et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med 47: 1175-1180, 2008.","DOI":"10.2169\/internalmedicine.47.0603"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ter Maaten JC, Voorburg A, Heine RJ, Ter Wee PM, Donker AJ, Gans RO. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 92: 51-58, 1997.","DOI":"10.1042\/cs0920051"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lee J, Lee JY, Lee JH, et al. Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study. Arthritis Res Ther 17: 79, 2015.","DOI":"10.1186\/s13075-015-0593-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Matsuo H, Nakayama A, Sakiyama M, et al. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload. Sci Rep 4: 3755, 2014.","DOI":"10.1038\/srep03755"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chowalloor PV, Siew TK, Keen HI. Imaging in gout: a review of the recent developments. Ther Adv Musculoskelet Dis 6: 131-143, 2014.","DOI":"10.1177\/1759720X14542960"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Fernandes A, Faria MT, Oliveira A, Vieira T, Pereira J. Bone scintigraphy in tophaceous gout. Eur J Nucl Med Mol Imaging 43: 1387-1388, 2016.","DOI":"10.1007\/s00259-016-3336-2"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Goshen E, Schwartz A, Zwas ST. Chronic tophaceous gout: scintigraphic findings on bone scan. Clin Nucl Med 25: 146-147, 2000.","DOI":"10.1097\/00003072-200002000-00019"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Coombs RJ, Pinsky ST, Padanilam TG. Bone scan findings of combined gout and septic arthritis in the same digit. Clin Nucl Med 26: 442-443, 2001.","DOI":"10.1097\/00003072-200105000-00012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Appelboom T, Emery P, Tant L, Dumarey N, Schoutens A. Evaluation of technetium-99m-ciprofloxacin (Infecton) for detecting sites of inflammation in arthritis. Rheumatology (Oxford) 42: 1179-1182, 2003.","DOI":"10.1093\/rheumatology\/keg321"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Dalbeth N, Smith T, Nicolson B, et al. Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells. Arthritis Rheum 58: 1854-1865, 2008.","DOI":"10.1002\/art.23488"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Schlesinger N, Thiele RG. The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis 69: 1907-1912, 2010.","DOI":"10.1136\/ard.2010.128454"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mundy GR. Osteoporosis and inflammation. Nutr Rev 65: S147-S151, 2007.","DOI":"10.1301\/nr.2007.dec.S147-S151"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Chhana A, Dalbeth N. The gouty tophus: a review. Curr Rheumatol Rep 17: 19, 2015.","DOI":"10.1007\/s11926-014-0492-x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Oshima K, Nampei A, Matsuda M, et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 331: 520-526, 2005.","DOI":"10.1016\/j.bbrc.2005.03.210"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/9\/56_56.7923\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T11:44:55Z","timestamp":1498391095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/9\/56_56.7923\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7923","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}